Venter makes new hires at Synthetic Genomics and Human Longevity

J. Craig Venter has made new hires at two of his companies. Barry Merriman and Paul Mola have joined life-extension startup Human Longevity to pitch the company's capabilities to potential clients and partners, including foreign governments, national healthcare systems and health charities. Oliver Fetzer is the new face at Synthetic Genomics. Fetzer has replaced Venter as CEO. Release I More

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.